The Thrombogram in Rare Inherited Coagulation Disorders: Its Relation to Clinical Bleeding

We investigated the relation between clotting factor concentration, the parameters of the thrombin generation curve (the thrombogram) and the severity of clinically observed bleeding in patients with congenital deficiency of prothrombin (n = 21), factor V (n = 22), factor VII (n = 22), factor X (n = 10), factor XI (n = 7) and factor XII (n = 6). The parameters used were: area under the curve (endogenous thrombin potential, ETP), peak concentration of thrombin attained and lag time before manifest formation. Peak height and ETP varied linearly with the concentration of prothrombin. For the other factors these parameters hyperbolically approached to the 100% limit with increasing clotting factor concentration. Half normal ETP was seen at about the following concentrations: prothrombin (50%), factor V (1%), factor VII (2%), factor X (5%) and factor XI (1%). As a rule, the peak height was some-what more sensitive to clotting factor decrease than the ETP was. In all the patients with severe bleeding symptoms the ETP was less than 20% of normal. Bleeding tendency was absent or mild in patients with an ETP of 30% or higher. This value (except for prothrombin) is already obtained at concentrations of clotting factor of 1%-2%, which corroborates the clinical observation that a severe bleeding tendency is only seen in severe clotting factor deficiencies (less than 1%). The one exception was a patient with factor VII deficiency and severe bleeding, who showed a normal ETP value, albeit with a decreased peak height and a prolonged lag-time.

[1]  H. Hemker,et al.  Design and synthesis of thrombin substrates with modified kinetic parameters. , 1995, Thrombosis research.

[2]  H. Hemker,et al.  A Computer Assisted Method to Obtain the Prothrombin Activation Velocity in Whole Plasma Independent of Thrombin Decay Processes , 1986, Thrombosis and Haemostasis.

[3]  S. Béguin,et al.  The Thrombogram: Monitoring Thrombin Generation in Platelet Rich Plasma , 2000, Thrombosis and Haemostasis.

[4]  P. Mannucci,et al.  Rare Coagulation Disorders , 1999, Thrombosis and Haemostasis.

[5]  P. Mannucci,et al.  Identification and Three-dimensional Structural Analysis of Nine Novel Mutations in Patients with Prothrombin Deficiency , 2000, Thrombosis and Haemostasis.

[6]  H. Hemker,et al.  Activation of human prothrombin by stoichiometric levels of staphylocoagulase. , 1983, The Journal of biological chemistry.

[7]  P. Mannucci,et al.  Clinical manifestations in 28 Italian and Iranian patients with severe factor VII deficiency , 1997, Haemophilia : the official journal of the World Federation of Hemophilia.

[8]  F. Peyvandi,et al.  Symptoms of inherited factor V deficiency in 35 Iranian patients , 1998, British journal of haematology.

[9]  H. Hemker,et al.  The Mode of Action of Heparin in Plasma , 1988, Thrombosis and Haemostasis.

[10]  H. Hemker,et al.  Continuous Registration of Thrombin Generation in Plasma, Its Use for the Determination of the Thrombin Potential , 1993, Thrombosis and Haemostasis.

[11]  P. Mannucci,et al.  Congenital factor X deficiency: spectrum of bleeding symptoms in 32 Iranian patients , 1998, British journal of haematology.

[12]  H. Hemker,et al.  The Role of Factor XI in Thrombin Generation Induced by Low Concentrations of Tissue Factor , 2001, Thrombosis and Haemostasis.

[13]  S. Perkins,et al.  Molecular Characterisation and Three-Dimensional Structural Analysis of Mutations in 21 Unrelated Families with Inherited Factor VII Deficiency , 2000, Thrombosis and Haemostasis.

[14]  K. Mann,et al.  "Normal" thrombin generation. , 1999, Blood.

[15]  Risk of stroke during long‐term anticosgulant therapy in patients after myocardial infarction , 1996, Annals of neurology.

[16]  E. Santagostino,et al.  A novel two base pair deletion in the factor V gene associated with severe factor V deficiency. , 2000 .

[17]  H C Hemker,et al.  The role of phospholipids and factor Va in the prothrombinase complex. , 1980, The Journal of biological chemistry.

[18]  V. Kakkar,et al.  The Routine Determination of the Endogenous Thrombin Potential, First Results in Different Forms of Hyper- and Hypocoagulability , 1997, Thrombosis and Haemostasis.

[19]  H. Hemker,et al.  Phenotyping the Clotting System , 2002, Thrombosis and Haemostasis.

[20]  S. Perkins,et al.  Abnormal secretion and function of recombinant human factor VII as the result of modification to a calcium binding site caused by a 15-base pair insertion in the F7 gene. , 2001, Blood.

[21]  P. Mannucci,et al.  Bleeding and thrombosis in 55 patients with inherited afibrinogenaemia , 1999, British journal of haematology.

[22]  P. Mannucci,et al.  Missense mutations in the human beta fibrinogen gene cause congenital afibrinogenemia by impairing fibrinogen secretion. , 2000, Blood.

[23]  P. Mannucci,et al.  Coexistence of a novel homozygous nonsense mutation in exon 13 of the factor V gene with the homozygous Leiden mutation in two unrelated patients with severe factor V deficiency , 2001, British journal of haematology.